Search results

Please enter search term
Saughter and May advised the Central Bank of Egypt on a $3.8 billion syndicated repurchase transaction Central Bank of Egypt on a $3.8 billion syndicated repurchase transaction Saughter and May advised Daily Mail and General Trust Plc on its proposed distributions to shareholders Daily Mail and General Trust Plc on its proposed distributions to shareholders Saughter and May advised COSCO SHIPPING Ports in relation to its conditional agreement to subscribe for 60% of the shares in Terminales Portuarios Chancay S.A. for US$225 million Saughter and May advised COSCO SHIPPING Ports in relation to its conditional agreement to subscribe for 60% of the shares in Terminales Portuarios Chancay S.A. for US$225 million Saughter and May advised the Quartz group on a minority investment into the group by Inflexion Quartz group on a minority investment into the group by Inflexion Saughter and May is advising Greencore Group plc on English aspects of its proposed return of capital of up to £509 million to shareholders Greencore Group plc on English aspects of its proposed return of capital of up to £509 million to shareholders Saughter and May advised the Arsenal Football Club on the battery storage project with Pivot Power at Emirates Stadium Arsenal Football Club on the battery storage project with Pivot Power at Emirates Stadium Saughter and May advised BHP Billiton on the disposal of interests in the Bruce and Keith North Sea oil and gas fields to Serica Energy BHP Billiton on the disposal of interests in the Bruce and Keith North Sea oilfields to Serica Energy Saughter and May advised Dometic on its acquisition of Kampa Dometic on its acquisition of Kampa Saughter and May is advising GlaxoSmithKline plc on the financing of its acquisition of TESARO, Inc. GlaxoSmithKline plc on the financing of its acquisition of TESARO, Inc. Saughter and May is advising Hikma Pharmaceuticals PLC in relation to its acquisition of Medlac Pharma Italy, Co. Ltd. Hikma Pharmaceuticals PLC in relation to its acquisition of Medlac Pharma Italy, Co. Ltd.